Other investigators argue that the balance of PD-1 expression on tumor-infiltrating effector T cells and regulatory T cells correlates with the therapeutic effect of PD-1/PD-L1 inhibitor therapy and may predict the therapeutic effect with high accuracy [25]. The gene discussed is PDCD1; the disease is neoplasm.